Harrow, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Harrow, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Tangible Net Worth Ratio: Goodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative. Less tangible than 96% of Healthcare companies in United States.
- Debt Due Cover Ratio: Debt due within a year is covered 49.5 times by its yearly operating cash. Higher than 95% of Healthcare companies in United States.
- Steadiness Ratio: Sales grew in 3 of the last 3 years; profit grew in 2 of 3. Steadier than 85% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
0.1×Over the last 3 years its own operating cash paid for 13% of its investment spending (capex); the rest came from other sources such as borrowing, cash reserves or new shares.
Higher than 64% of Healthcare companies in United States.
Cash Locked Ratio
$33For every $100 of sales, $33 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $7 tied up three years earlier.
More money tied up than 70% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
3/3 · 2/3Sales grew in 3 of the last 3 years; profit grew in 2 of 3.
Steadier than 85% of Healthcare companies in United States.
Growth Efficiency Ratio
$5Sales grew 207% in 3 years; of every extra $100 of sales, $5 became extra profit.
Lower than 62% of Healthcare companies in United States.
Asset Productivity Ratio
+207% / +154%In 3 years sales changed by +207% while total assets changed by +154%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
49.5×Debt due within a year is covered 49.5 times by its yearly operating cash.
Higher than 95% of Healthcare companies in United States.
Cash Cushion Ratio
−17%Debt, after subtracting cash, equals 17% of its market value (net debt).
Lower than 82% of Healthcare companies in United States.
Tangible Assets Ratio
56%Of every $100 the company owns, $56 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 73% of Healthcare companies in United States.
Tangible Net Worth Ratio
NegativeGoodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative.
Less tangible than 96% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Harrow, Inc. made a loss over the last year. Harrow, Inc. owes $0.96 for every $1 it owns. Harrow, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossHarrow, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
70.14The share price is 70.14 times Harrow, Inc.'s book value per share, higher than 98% of Healthcare companies in United States.
Market cap
$1.1 BThe total market value of all of Harrow, Inc.'s shares at today's price (share price × number of shares), larger than 65% of Healthcare companies in United States. PosiCap size class: Meso Cap.
Net worth (book value)
$15 MWhat Harrow, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$0.41Net worth divided by the number of shares. The share price of $28.44 is 70.1 times this, which is the P/B above.
Return on equity (ROE)
-116.1%Harrow, Inc. lost 116.1% of its shareholders' money over the last year, lower than 75% of Healthcare companies in United States.
Owes vs Owns
0.96×Harrow, Inc. owes $0.96 for every $1 it owns (high), higher than 86% of Healthcare companies in United States.
Dividend yield
NoneHarrow, Inc. does not currently pay a dividend.
Revenue growth
+36%Revenue rose 36% in the year to Dec 2025, and grew 45% a year on average over 3 years.
Profit growth
LossHarrow, Inc. made a loss in each of the last two years.
Profit margin
-1.9%Harrow, Inc. lost $2 for every $100 of revenue.
Interest cover
1.3×Harrow, Inc.'s operating profit covered its interest costs 1.3 times in the year to Dec 2025.
Cash vs debt
Net debtHarrow, Inc. had $179 M more debt than cash (net debt) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Harrow, Inc.: $1.1 B ÷ $15 M (30 Jun 2026) = 70.1.
What is Harrow, Inc.'s return on equity?
Harrow, Inc. lost 116.1% of its shareholders' money over the last year, lower than 75% of Healthcare companies in United States.
How much does Harrow, Inc. owe compared with what it owns?
Harrow, Inc. owes $0.96 for every $1 it owns (high), higher than 86% of Healthcare companies in United States.
Does Harrow, Inc. pay a dividend?
No. Harrow, Inc. does not currently pay a dividend.
Is Harrow, Inc.'s revenue growing?
Revenue rose 36% in the year to Dec 2025, and grew 45% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.